Replies to post #349823 on Innovation Pharmaceuticals Inc (IPIX)

[LilyGDog]

Brilacidin’s ability to disrupt viral integrity suggests Brilacidin likely is not subject to resistance developing due to coronavirus variants—unlike current COVID-19 treatments, such as monoclonal antibodies and convalescent plasma, and first-generation COVID-19 vaccines. This mechanism of action supports Brilacidin as a clearly differentiated antiviral in clinical development.

[Basil22]

More great news.
Go IPIX. Save the World

[sunspotter]

"PR OUT"

That's more like the Leo Ehrlich the incontinent issuer of PRs we all know from his past record.

Issue a PR about an article that was originally published on February 9, and widely discussed since then including on this very MB:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161807568

while pretending it's new news:

"Received: 12 January 2021 / Revised: 28 January 2021 / Accepted: 5 February 2021 / Published: 9 February 2021"

https://www.mdpi.com/1999-4915/13/2/271

[TheDane]

It’s two week old NEWS! to IPIX shareholding posters but great news to get out to the public. Maybe something will catch eventually. I’m holding my shares but not my breath.

Go IPIX!

[MinnieM]

Many like to see a published article... and, it's good that he's calling attention to it. Although, most reading this board have been fully aware of it, most of the general public doesn't know about it.

Again, thanks for posting the reminder.